These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1216 related articles for article (PubMed ID: 26471778)
21. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells. Bianchi G; Borgonovo G; Pistoia V; Raffaghello L Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223 [TBL] [Abstract][Full Text] [Related]
22. Interaction of MSC with tumor cells. Melzer C; Yang Y; Hass R Cell Commun Signal; 2016 Sep; 14(1):20. PubMed ID: 27608835 [TBL] [Abstract][Full Text] [Related]
23. Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis. Brown GT; Murray GI J Pathol; 2015 Nov; 237(3):273-81. PubMed ID: 26174849 [TBL] [Abstract][Full Text] [Related]
24. Hallmarks of cancer: interactions with the tumor stroma. Pietras K; Ostman A Exp Cell Res; 2010 May; 316(8):1324-31. PubMed ID: 20211171 [TBL] [Abstract][Full Text] [Related]
25. Melanoma's connections to the tumour microenvironment. Brandner JM; Haass NK Pathology; 2013 Aug; 45(5):443-52. PubMed ID: 23851614 [TBL] [Abstract][Full Text] [Related]
26. Tumor microenvironment-mediated chemoresistance in breast cancer. Velaei K; Samadi N; Barazvan B; Soleimani Rad J Breast; 2016 Dec; 30():92-100. PubMed ID: 27668856 [TBL] [Abstract][Full Text] [Related]
27. Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis. Kim JB; Stein R; O'Hare MJ Tumour Biol; 2005; 26(4):173-85. PubMed ID: 16006771 [TBL] [Abstract][Full Text] [Related]
29. The tumour microenvironment as an integrated framework to understand cancer biology. Burgos-Panadero R; Lucantoni F; Gamero-Sandemetrio E; Cruz-Merino L; Álvaro T; Noguera R Cancer Lett; 2019 Oct; 461():112-122. PubMed ID: 31325528 [TBL] [Abstract][Full Text] [Related]
30. Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis. Hemmings C Pathology; 2013 Jun; 45(4):371-81. PubMed ID: 23594691 [TBL] [Abstract][Full Text] [Related]
31. Immunotherapy: target the stroma to hit the tumor. Kammertoens T; Schüler T; Blankenstein T Trends Mol Med; 2005 May; 11(5):225-31. PubMed ID: 15882610 [TBL] [Abstract][Full Text] [Related]
32. Role of stromal fibroblasts in cancer: promoting or impeding? Angeli F; Koumakis G; Chen MC; Kumar S; Delinassios JG Tumour Biol; 2009; 30(3):109-20. PubMed ID: 19440007 [TBL] [Abstract][Full Text] [Related]
33. Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer. Galván JA; Zlobec I; Wartenberg M; Lugli A; Gloor B; Perren A; Karamitopoulou E Br J Cancer; 2015 Jun; 112(12):1944-50. PubMed ID: 25989272 [TBL] [Abstract][Full Text] [Related]
34. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Mueller MM; Fusenig NE Differentiation; 2002 Dec; 70(9-10):486-97. PubMed ID: 12492491 [TBL] [Abstract][Full Text] [Related]
36. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts. Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625 [TBL] [Abstract][Full Text] [Related]
37. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cirri P; Chiarugi P Cancer Metastasis Rev; 2012 Jun; 31(1-2):195-208. PubMed ID: 22101652 [TBL] [Abstract][Full Text] [Related]
38. Extracellular matrix secreted by reactive stroma is a main inducer of pro-tumorigenic features on LNCaP prostate cancer cells. Palumbo A; Ferreira LB; Reis de Souza PA; Oliveira FL; Pontes B; Viana NB; Machado DE; Palmero CY; Alves LM; Gimba ER; Nasciutti LE Cancer Lett; 2012 Aug; 321(1):55-64. PubMed ID: 22388175 [TBL] [Abstract][Full Text] [Related]